MAL05041872TTraditional Herbal (MAL-T)

RENSHEN GUIPI WAN (PILL) 200MG

Generic Molecule: Dimocarpus Longan

ACTIVE & APPROVEDValid till: 2 May 2030
NPRA Official Regulatory Summary

RENSHEN GUIPI WAN (PILL) 200MG is a KKM-approved Traditional & Herbal registered under MAL number MAL05041872T by HAI-O MEDICINE SDN. BHD.. Its active ingredient is Dimocarpus longan 695.97 mg 6 g, SEMEN ZIZIPHUS JUJABA 347.97 mg 6 g, Radix Polygala Tenuifolia Wild 695.97 mg 6 g, PORIA COCOS WOLF 677.64 mg 6 g, Radix Glycyrrhiza Uralensis 183.13 mg 6 g, RADIX ANGELICA SINENSIS 695.97 mg 6 g, radix panax ginsen 347.97 mg 6 g, Rhizoma Atractylodes Macrocephala 677.64 mg 6 g, Radix Astragalus Membaranaceus 347.97 mg 6 g, manufactured by BEIJING TONG REN TANG CO. LTD.

Holder (PRH)
HAI-O MEDICINE SDN. BHD.
Manufacturer
BEIJING TONG REN TANG CO. LTD
First Registered
2 May 2025
Validity
2 May 2030

Check Verified Pharmacy Stock & Best Price

Compare retail prices across licensed Malaysian pharmacies (Watsons, Guardian, Big Pharmacy, Shopee Mall).

Active Ingredients & Strength Formulation

9 Components
Active Substance / MoleculeDeclared Strength / DosageGeneric Directory
Dimocarpus longan695.97 mg 6 gFind Brands
SEMEN ZIZIPHUS JUJABA347.97 mg 6 gFind Brands
Radix Polygala Tenuifolia Wild695.97 mg 6 gFind Brands
PORIA COCOS WOLF677.64 mg 6 gFind Brands
Radix Glycyrrhiza Uralensis183.13 mg 6 gFind Brands
RADIX ANGELICA SINENSIS695.97 mg 6 gFind Brands
radix panax ginsen347.97 mg 6 gFind Brands
Rhizoma Atractylodes Macrocephala677.64 mg 6 gFind Brands
Radix Astragalus Membaranaceus347.97 mg 6 gFind Brands
Dosage values indicate declared active concentration per unit dose as registered with NPRA Malaysia.

Sole Registered Brand Formulation

This product is currently the primary or innovator formulation registered in Malaysia under Dimocarpus Longan.

Malaysian KKM Security Hologram Verification

FarmaChecker & Meditag™

By Malaysian Ministry of Health (KKM) regulation, all genuine registered pharmaceuticals, health supplements (MAL-N), and traditional products (MAL-T) distributed in Malaysia must feature an official tamper-evident security hologram sticker on the physical packaging.

1. Visual Tilt Check

Tilt the box under light to view the micro-engraved KKM coat of arms and multi-layer iridescent security patterns.

2. Match MAL Number

Ensure the printed MAL code matches MAL05041872T exactly on label and box.

3. FarmaChecker Scan

Scan using the official FarmaChecker app on iOS / Android to authenticate serial token with NPRA servers.

If the packaging lacks a security hologram or fails the FarmaChecker scan, do not consume and report to Cawangan Penguatkuasaan Farmasi (CPF KKM).
Frequently Asked Questions & Verification Details

Is RENSHEN GUIPI WAN (PILL) 200MG approved by KKM / NPRA?

Yes. RENSHEN GUIPI WAN (PILL) 200MG is actively registered with the National Pharmaceutical Regulatory Agency under official registration number MAL05041872T with current status PRODUCT APPROVED. Registration was filed by HAI-O MEDICINE SDN. BHD..

What are the active ingredients of RENSHEN GUIPI WAN (PILL) 200MG?

The declared active therapeutic components are: Dimocarpus longan 695.97 mg 6 g, SEMEN ZIZIPHUS JUJABA 347.97 mg 6 g, Radix Polygala Tenuifolia Wild 695.97 mg 6 g, PORIA COCOS WOLF 677.64 mg 6 g, Radix Glycyrrhiza Uralensis 183.13 mg 6 g, RADIX ANGELICA SINENSIS 695.97 mg 6 g, radix panax ginsen 347.97 mg 6 g, Rhizoma Atractylodes Macrocephala 677.64 mg 6 g, Radix Astragalus Membaranaceus 347.97 mg 6 g. Always follow dosage recommendations prescribed by a certified doctor or licensed pharmacist.

What are the registered generic alternatives in Malaysia?

In Malaysia, there are 1 registered brand formulations containing identical active ingredients (Dimocarpus Longan). You can review them in the alternative brands section above or consult your community pharmacist for generic bioequivalent substitution.

Semakan status pendaftaran KKM / NPRA: RENSHEN GUIPI WAN (PILL) 200MG (MAL05041872T) | Pengganti ubat di Malaysia | Bahan aktif ubat & maklumat farmasi.